Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Closse-up,Shot,Of,White,Pills,On,Conveyor,At,Modern,Pharmaceutical

President Donald Trump has given generic-drug manufacturers a choice – add U.S. capacity within two years or face tariffs.

Writing on Truth Social, Trump framed the measure as one designed to “RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time.”